RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

A Penn-Nicholson, SK Mbandi, E Thompson… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic …

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

SC Mendelsohn, A Fiore-Gartland… - The Lancet Global …, 2021 - thelancet.com
Background A rapid, blood-based triage test that allows targeted investigation for
tuberculosis at the point of care could shorten the time to tuberculosis treatment and reduce …

Detection of tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on antiretroviral therapy

F Darboe, SK Mbandi, K Naidoo… - Frontiers in …, 2019 - frontiersin.org
HIV-infected individuals are at high risk of tuberculosis disease and those with prior
tuberculosis episodes are at even higher risk of disease recurrence. A non-sputum …

Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study

CT Turner, RK Gupta, E Tsaliki, JK Roe… - The Lancet …, 2020 - thelancet.com
Background Blood transcriptional signatures are candidates for non-sputum triage or
confirmatory tests of tuberculosis. Prospective head-to-head comparisons of their diagnostic …

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis

H Mulenga, CZ Zauchenberger, EW Bunyasi… - PLoS …, 2020 - journals.plos.org
Introduction Host blood transcriptomic biomarkers have potential as rapid point-of-care
triage, diagnostic, and predictive tests for Tuberculosis disease. We aimed to summarise the …

[HTML][HTML] Host blood RNA signatures predict the outcome of tuberculosis treatment

EG Thompson, Y Du, ST Malherbe, S Shankar, J Braun… - Tuberculosis, 2017 - Elsevier
Biomarkers for tuberculosis treatment outcome will assist in guiding individualized treatment
and evaluation of new therapies. To identify candidate biomarkers, RNA sequencing of …

Concise gene signature for point‐of‐care classification of tuberculosis

J Maertzdorf, G McEwen, J Weiner 3rd… - EMBO molecular …, 2016 - embopress.org
There is an urgent need for new tools to combat the ongoing tuberculosis (TB) pandemic.
Gene expression profiles based on blood signatures have proved useful in identifying genes …

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis

RK Gupta, CT Turner, C Venturini, H Esmail… - The Lancet …, 2020 - thelancet.com
Background Multiple blood transcriptional signatures have been proposed for identification
of active and incipient tuberculosis. We aimed to compare the performance of systematically …

Diagnostic biomarkers for active tuberculosis: progress and challenges

BMF Nogueira, S Krishnan… - EMBO Molecular …, 2022 - embopress.org
Tuberculosis (TB) is a leading cause of morbidity and mortality from a single infectious
agent, despite being preventable and curable. Early and accurate diagnosis of active TB is …

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: a prospective cohort study

A Penn-Nicholson, T Hraha, EG Thompson… - PLoS …, 2019 - journals.plos.org
Background A nonsputum blood test capable of predicting progression of healthy individuals
to active tuberculosis (TB) before clinical symptoms manifest would allow targeted treatment …